SMS Pharmaceuticals Limited (SMSPHARMA.NS)
SMS Pharmaceuticals Limited operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Hyderabad, TS, IN. The stock last traded at $361.35, down 1.08% on the session, giving a market capitalisation of $33.84B. Its beta of 1.15 implies it has historically moved more than the broad market.
SMS Pharmaceuticals Limited, an Indian company established in 1987 and based in Hyderabad, specializes in the production and distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The firm offers a wide array of APIs targeting various therapeutic categories, including anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral applications. Furthermore, SMS Pharmaceuticals engages in contract research activities and exports its products globally.
SMS Pharmaceuticals Limited is most often compared with the following Healthcare names: